Pivotal mental states
Open accessThe DOI matches its Crossref record; 168 of the 168 references it cites were found in a registry or an index.
Abstract
This paper introduces a new construct, the ‘pivotal mental state’, which is defined as a hyper-plastic state aiding rapid and deep learning that can mediate psychological transformation. We believe this new construct bears relevance to a broad range of psychological and psychiatric phenomena. We argue that pivotal mental states serve an important evolutionary function, that is, to aid psychological transformation when actual or perceived environmental pressures demand this. We cite evidence that chronic stress and neurotic traits are primers for a pivotal mental state, whereas acute stress can be a trigger. Inspired by research with serotonin 2A receptor agonist psychedelics, we highlight how activity at this particular receptor can robustly and reliably induce pivotal mental states, but we argue that the capacity for pivotal mental states is an inherent property of the human brain itself. Moreover, we hypothesize that serotonergic psychedelics hijack a system that has evolved to mediate rapid and deep learning when its need is sensed. We cite a breadth of evidences linking stress via a variety of inducers, with an upregulated serotonin 2A receptor system (e.g. upregulated availability of and/or binding to the receptor) and acute stress with 5-HT release, which we argue can activate this primed system to induce a pivotal mental state. The pivotal mental state model is multi-level, linking a specific molecular gateway (increased serotonin 2A receptor signaling) with the inception of a hyper-plastic brain and mind state, enhanced rate of associative learning and the potential mediation of a psychological transformation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Need for a New Medical Model: A Challenge for Biomedicine
Engel, G. L. (1977) · Science · doi:10.1126/science.847460 · Cited by 12,887
Whatever next? Predictive brains, situated agents, and the future of cognitive science
Clark, A. (2013) · Behavioral and Brain Sciences · doi:10.1017/s0140525x12000477 · Cited by 5,924 · cited 1×
“…and function appears to be organized hierarchically (Felleman and Van, 1991; Margulies et al., 2016) and it is proposed that relevant predictive mechanisms are encoded in the brain’s multi-level functional and anatomical hierarchies (Clark, 2013; Friston, 2018; Rao and Ballard, 1999; Seth, 2013).”
BackgroundRao, R. P. N., & Ballard, D. H. (1999) · Nature Neuroscience · doi:10.1038/4580 · Cited by 5,483 · cited 1×
“…and function appears to be organized hierarchically (Felleman and Van, 1991; Margulies et al., 2016) and it is proposed that relevant predictive mechanisms are encoded in the brain’s multi-level functional and anatomical hierarchies (Clark, 2013; Friston, 2018; Rao and Ballard, 1999; Seth, 2013).”
BackgroundBeyond diathesis stress: differential susceptibility to environmental influences
Belsky, J., & Pluess, M. (2009) · Psychological Bulletin · doi:10.1037/a0017376 · Cited by 3,039 · cited 1×
“The link between stress and psychosis is well established and consistent with the ‘diathesis-stress’ model of psychopathology in which pre-existing vulnerabilities (diathesis = predisposition) combine with stress to catalyse transition into illness (Belsky and Pluess, 2009).”
ResultThe Dopamine Hypothesis of Schizophrenia: Version III--The Final Common Pathway
Howes, O. D., & Kapur, S. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp006 · Cited by 2,693 · cited 3×
“Beyond the hypothesized involvement of the 5-HT2AR in the induction of psychotic states (Carhart-Harris et al., 2014b; Geyer and Vollenweider, 2008), it is generally thought that dopaminergic (DA) dysregulation serves as a ‘final common pathway’ underlying chronic psychoses (Howes and Kapur, 2009).”
BackgroundChildhood adversities and adult psychopathology in the WHO World Mental Health Surveys
Kessler, R. C., McLaughlin, K. A., Green, J. G., Gruber, M. J., Sampson, N. A., Zaslavsky, A. M., Aguilar-Gaxiola, S., Alhamzawi, A. O., Alonso, J., Angermeyer, M., et al. (2010) · British Journal of Psychiatry · doi:10.1192/bjp.bp.110.080499 · Cited by 2,640
Varese, F., Smeets, F., Drukker, M., Lieverse, R., Lataster, T., Viechtbauer, W., Read, J., van Os, J., & Bentall, R. P. (2012) · Schizophrenia Bulletin · doi:10.1093/schbul/sbs050 · Cited by 2,436 · cited 3×
“Psychological trauma predisposes certain individuals towards dissociation, hallucination and other psychotic-like features (Kilcommons and Morrison, 2005; McCarthy-Jones and Longden, 2015; Varese et al., 2012a).”
BackgroundClark, D. M. (1986) · Behaviour Research and Therapy · doi:10.1016/0005-7967(86)90011-2 · Cited by 2,422 · cited 1×
“…of the 5-HT2AR may also precipitate psychotic symptoms during panic attacks (Galynker et al., 1996; Goodwin and Davidson, 2002; Masdrakis et al., 2017), which often involve a physiological disturbance (e.g. hypercapnia) coupled with cognitive misinterpretation (Clark, 1986; Vollmer et al., 2015).”
BackgroundSituating the default-mode network along a principal gradient of macroscale cortical organization
Margulies, D. S., Ghosh, S. S., Goulas, A., Falkiewicz, M., Huntenburg, J. M., Langs, G., Bezgin, G., Eickhoff, S. B., Castellanos, F. X., Petrides, M., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1608282113 · Cited by 2,321 · cited 1×
“Much of brain anatomy and function appears to be organized hierarchically (Felleman and Van, 1991; Margulies et al., 2016) and it is proposed that relevant predictive mechanisms are encoded in the brain’s multi-level functional and anatomical hierarchies (Clark, 2013; Friston, 2018; Rao and…”
BackgroundGriffiths, R. R., Johnson, M. W., Carducci, M. A., Umbricht, A., Richards, W. A., Richards, B. D., Cosimano, M. P., & Klinedinst, M. A. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116675513 · Cited by 2,201 · cited 1×
“…phenomenology of the psychedelic state, peak, mystical-type or spiritual experiences and associated feelings of oceanic boundlessness have been found to reliably predict positive outcomes in psychedelic therapy (Griffiths et al., 2016; Haijen et al., 2018; Roseman et al., 2018; Ross et al., 2016).”
BackgroundThe SPQ: A Scale for the Assessment of Schizotypal Personality Based on DSM-III-R Criteria
Raine, A. (1991) · Schizophrenia Bulletin · doi:10.1093/schbul/17.4.555 · Cited by 2,164
STRESS AND HIPPOCAMPAL PLASTICITY
McEwen, B. S. (1999) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.22.1.105 · Cited by 2,087 · cited 2×
“Thus, it would be hasty to cite evidence of the negative impact of chronic stress on regionally specific neuronal integrity (e.g. McEwen, 1999) or aberrant synaptic plasticity in schizophrenia (Stephan et al., 2009) as evidence against the model being presented here.”
BackgroundInteroceptive inference, emotion, and the embodied self
Seth, A. K. (2013) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2013.09.007 · Cited by 1,816 · cited 1×
“…and function appears to be organized hierarchically (Felleman and Van, 1991; Margulies et al., 2016) and it is proposed that relevant predictive mechanisms are encoded in the brain’s multi-level functional and anatomical hierarchies (Clark, 2013; Friston, 2018; Rao and Ballard, 1999; Seth, 2013).”
BackgroundUncertainty, Neuromodulation, and Attention
Yu, A. J., & Dayan, P. (2005) · Neuron · doi:10.1016/j.neuron.2005.04.026 · Cited by 1,774
Nichols, D. E. (2016) · Pharmacological Reviews · doi:10.1124/pr.115.011478 · Cited by 1,762
Neural mechanisms of the cognitive model of depression.
Disner, S. G., Beevers, C. G., Haigh, E. A. P., & Beck, A. T. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3027 · Cited by 1,718 · cited 1×
“For example, a negative (cognitive) bias characterizing a depressive disorder (Disner et al., 2011) would be felt less confidently if it were relaxed.”
BackgroundRoss, S., Bossis, A., Guss, J., Agin-Liebes, G., Malone, T., Cohen, B., Mennenga, S. E., Belser, A., Kalliontzi, K., Babb, J., et al. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116675512 · Cited by 1,698
Griffiths, R. R., Richards, W. A., McCann, U., & Jesse, R. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0457-5 · Cited by 1,684
Kilpatrick, D. G., Ruggiero, K. J., Acierno, R., Saunders, B. E., Resnick, H. S., & Best, C. L. (2003) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.71.4.692 · Cited by 1,590 · cited 8×
“The active suppression of emotion is associated with the nature and severity of symptomatology in psychosis and PTSD (Laloyaux et al., 2016; Roemer et al., 2001; Tull et al., 2018) and the duration of negative affect (but not its intensity) has been found to predict negative long-term outcomes after psychedelic drug u…”
BackgroundInfluentialCarhart-Harris, R. L., Bolstridge, M., Rucker, J., Day, C. M. J., Erritzoe, D., Kaelen, M., Bloomfield, M., Rickard, J. A., Forbes, B., Feilding, A., et al. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(16)30065-7 · Cited by 1,540 · cited 7×
“Under psychedelics, the normal functional segregation or specialization in the brain is instead replaced by a globally interconnected profile (Carhart-Harris et al., 2012a, 2016c; Lord et al., 2019; Petri et al., 2014; Preller et al., 2018; Smigielski et al., 2019; Tagliazucchi et al., 2014).”
BackgroundInfluentialSelf-citationCarhart-Harris, R. L., Leech, R., Hellyer, P. J., Shanahan, M., Feilding, A., Tagliazucchi, E., Chialvo, D. R., & Nutt, D. (2014) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2014.00020 · Cited by 1,252
Psychedelics promote structural and functional neural plasticity
Ly, C., Greb, A. C., Cameron, L. P., Wong, J. M., Barragan, E. V., Wilson, P. C., Burbach, K. F., Soltanzadeh Zarandi, S., Sood, A., Paddy, M. R., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.05.022 · Cited by 1,207
Human hallucinogen research: guidelines for safety
Johnson, M., Richards, W., & Griffiths, R. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881108093587 · Cited by 1,203
REBUS and the anarchic brain: Toward a unified model of the brain action of psychedelics
Carhart-Harris, R. L., & Friston, K. J. (2019) · Pharmacological Reviews · doi:10.1124/pr.118.017160 · Cited by 1,180
Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin
Carhart-Harris, R. L., Erritzoe, D., Williams, T., Stone, J. M., Reed, L. J., Colasanti, A., Tyacke, R. J., Leech, R., Malizia, A. L., Murphy, K., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1119598109 · Cited by 1,172 · cited 4×
“Under psychedelics, the normal functional segregation or specialization in the brain is instead replaced by a globally interconnected profile (Carhart-Harris et al., 2012a, 2016c; Lord et al., 2019; Petri et al., 2014; Preller et al., 2018; Smigielski et al., 2019; Tagliazucchi et al., 2014).”
BackgroundResultInfluentialSelf-citationPsilocybin-assisted treatment for alcohol dependence: A proof-of-concept study
Bogenschutz, M. P., Forcehimes, A. A., Pommy, J. A., Wilcox, C. E., Barbosa, P., & Strassman, R. J. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881114565144 · Cited by 1,151 · cited 1×
“…(a) personality (Erritzoe et al., 2018; Lebedev et al., 2016; MacLean et al., 2011); (b) mental health and wellbeing (Argento et al., 2017; Bogenschutz et al., 2015; Carhart-Harris et al., 2017, 2018b; Gasser et al., 2015; Griffiths et al., 2006, 2008; Haijen et al., 2018; Hendricks et…”
BackgroundDysconnection in schizophrenia: from abnormal synaptic plasticity to failures of self-monitoring
Stephan, K. E., Friston, K. J., & Frith, C. D. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn176 · Cited by 1,134 · cited 3×
“Thus, it would be hasty to cite evidence of the negative impact of chronic stress on regionally specific neuronal integrity (e.g. McEwen, 1999) or aberrant synaptic plasticity in schizophrenia (Stephan et al., 2009) as evidence against the model being presented here.”
BackgroundFalse Suffocation Alarms, Spontaneous Panics, and Related Conditions: An Integrative Hypothesis
Klein, D. F. (1993) · Archives of General Psychiatry · doi:10.1001/archpsyc.1993.01820160076009 · Cited by 1,130 · cited 1×
“Hypoxia is also implicated in near-death experiences (NDEs) (KlemencKetis et al., 2010; Van Lommel et al., 2001), ‘runners’ high’, high-altitude-induced psychosis (Hüfner et al., 2018), panic attacks (Klein, 1993; Roth et al., 2002) and spiritual practices and experiences (Nivethitha et al., 2017).”
BackgroundPsilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action
Vollenweider, F. X., Vollenweider-Scherpenhuyzen, M. F. I., Bäbler, A., Vogel, H., & Hell, D. (1998) · NeuroReport · doi:10.1097/00001756-199812010-00024 · Cited by 1,018 · cited 2×
“The psychotomimetic (psychosis-mimicking) effects of classic 5-HT2AR agonist psychedelics have been well documented (Carhart-Harris et al., 2016b; Gonzalez-Maeso and Sealfon, 2009; Quednow et al., 2020; Vollenweider et al., 1997, 1998).”
BackgroundPsilocybin with psychological support for treatment-resistant depression: six-month follow-up
Carhart-Harris, R. L., Bolstridge, M., Day, C. M. J., Rucker, J., Watts, R., Erritzoe, D. E., Kaelen, M., Giribaldi, B., Bloomfield, M., Pilling, S., et al. (2018) · Psychopharmacology · doi:10.1007/s00213-017-4771-x · Cited by 970 · cited 10×
“…factors need to be treated with special attention and therapeutic care (where possible) if an individual’s psychological wellbeing is to be safeguarded, whenever a PiMS arises or seems imminent (Carhart-Harris et al., 2018c; Hartogsohn, 2016; Hayes, 2019; Johnson et al., 2008; Leary et al., 1963).”
BackgroundInfluentialSelf-citationPsilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects
Griffiths, R. R., Johnson, M. W., Richards, W. A., Richards, B. D., McCann, U., & Jesse, R. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2358-5 · Cited by 932
Amat, J., Baratta, M. V., Paul, E., Bland, S. T., Watkins, L. R., & Maier, S. F. (2005) · Nature Neuroscience · doi:10.1038/nn1399 · Cited by 931
Pilot study of the 5-HT 2A R agonist psilocybin in the treatment of tobacco addiction
Johnson, M. W., Garcia-Romeu, A., Cosimano, M. P., & Griffiths, R. R. (2014) · Journal of Psychopharmacology · doi:10.1177/0269881114548296 · Cited by 914 · cited 1×
“…et al., 2015; Carhart-Harris et al., 2017, 2018b; Gasser et al., 2015; Griffiths et al., 2006, 2008; Haijen et al., 2018; Hendricks et al., 2015; Johnson et al., 2014; Osório et al., 2015; Moreno et al., 2006; Ross et al., 2016); (c) political perspective (Lyons and Carhart-Harris, 2018a; Nour…”
BackgroundGriffiths, R., Richards, W., Johnson, M., McCann, U., & Jesse, R. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881108094300 · Cited by 905
MacLean, K. A., Johnson, M. W., & Griffiths, R. R. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881111420188 · Cited by 895
WALLACE, A. F. C. (1956) · American Anthropologist · doi:10.1525/aa.1956.58.2.02a00040 · Cited by 883
Neural correlates of the LSD experience revealed by multimodal neuroimaging
Carhart-Harris, R. L., Muthukumaraswamy, S., Roseman, L., Kaelen, M., Droog, W., Murphy, K., Tagliazucchi, E., Schenberg, E. E., Nest, T., Orban, C., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1518377113 · Cited by 859 · cited 7×
“Under psychedelics, the normal functional segregation or specialization in the brain is instead replaced by a globally interconnected profile (Carhart-Harris et al., 2012a, 2016c; Lord et al., 2019; Petri et al., 2014; Preller et al., 2018; Smigielski et al., 2019; Tagliazucchi et al., 2014).”
BackgroundInfluentialSelf-citationRoseman, L., Nutt, D. J., & Carhart-Harris, R. L. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00974 · Cited by 808
Self-citationSafety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder
Moreno, F. A., Wiegand, C. B., Taitano, E. K., & Delgado, P. L. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n1110 · Cited by 789 · cited 1×
“…2018b; Gasser et al., 2015; Griffiths et al., 2006, 2008; Haijen et al., 2018; Hendricks et al., 2015; Johnson et al., 2014; Osório et al., 2015; Moreno et al., 2006; Ross et al., 2016); (c) political perspective (Lyons and Carhart-Harris, 2018a; Nour et al., 2017); (d) lifestyle preferences…”
BackgroundMismatch negativity in schizophrenia: a meta-analysis
Umbricht, D., & Krljes, S. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2004.12.002 · Cited by 742
Serotonin and brain function: a tale of two receptors
Carhart-Harris, R., & Nutt, D. (2017) · Journal of Psychopharmacology · doi:10.1177/0269881117725915 · Cited by 739 · cited 9×
“Somewhat consistent ideas have been expressed in the past (Jaynes, 1976), and more recently in two separate reviews (e.g. Carhart-Harris and Nutt, 2017; Murnane, 2019), but are more fully developed here.”
BackgroundResultInfluentialSelf-citationThe Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future
Carhart-Harris, R. L., & Goodwin, G. M. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.84 · Cited by 706 · cited 5×
“However, the duration of the therapeutic response associated with classic (direct 5-HT2AR agonist) psychedelics (Carhart-Harris and Goodwin, 2017) appears to exceed that associated with a single exposure to ketamine and although MDMA causes an appreciable increase in activity at the 5-HT2AR through…”
BackgroundMethodResultInfluentialSelf-citationJavitt, D. C., Steinschneider, M., Schroeder, C. E., & Arezzo, J. C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11962 · Cited by 662
Psychedelics and the essential importance of context
Carhart-Harris, R. L., Roseman, L., Haijen, E., Erritzoe, D., Watts, R., Branchi, I., & Kaelen, M. (2018) · Journal of Psychopharmacology · doi:10.1177/0269881118754710 · Cited by 657 · cited 10×
“…factors need to be treated with special attention and therapeutic care (where possible) if an individual’s psychological wellbeing is to be safeguarded, whenever a PiMS arises or seems imminent (Carhart-Harris et al., 2018c; Hartogsohn, 2016; Hayes, 2019; Johnson et al., 2008; Leary et al., 1963).”
BackgroundInfluentialSelf-citationEpley, N., Akalis, S., Waytz, A., & Cacioppo, J. T. (2008) · Psychological Science · doi:10.1111/j.1467-9280.2008.02056.x · Cited by 632
5-Hydroxytryptamine (serotonin) in the gastrointestinal tract
Gershon, M. D. (2013) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0b013e32835bc703 · Cited by 617 · cited 1×
“Serotonin is an endogenous monoamine found throughout the body, particularly in the gastrointestinal system (Gershon, 2013), lungs (Castro et al., 2017) and, to a lesser extent, the central nervous system.”
BackgroundCognitive-perceptual, interpersonal, and disorganized features of schizotypal personality
Raine, A., Reynolds, C., Lencz, T., Scerbo, A., Triphon, N., & Kim, D. (1994) · Schizophrenia Bulletin · doi:10.1093/schbul/20.1.191 · Cited by 595 · cited 1×
“…the details of this are beyond the scope of this article. adjustment, behaviour and appearance (Davidson et al., 2016; Garssen et al., 2016; Raine, 1991; Raine et al., 1994), which capture divergent responses to ego-disturbance, perceptual aberration and magical thinking (Crespi et al., 2019).”
BackgroundWatts, R., Day, C., Krzanowski, J., Nutt, D., & Carhart-Harris, R. (2017) · Journal of Humanistic Psychology · doi:10.1177/0022167817709585 · Cited by 589 · cited 4×
“…can be found in reports of post-traumatic growth after recovery from psychosis and other severe conditions (Slade et al., 2019), neardeath experiences (Geiger, 2009; Khanna and Greyson, 2015) and in cases of clinical breakthrough with psychedelic therapy (Roseman et al., 2019; Watts et al., 2017).”
BackgroundMethodInfluentialSelf-citationPsilocybin for treatment-resistant depression: fMRI-measured brain mechanisms
Carhart-Harris, R. L., Roseman, L., Bolstridge, M., Demetriou, L., Pannekoek, J. N., Wall, M. B., Tanner, M., Kaelen, M., McGonigle, J., Murphy, K., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-13282-7 · Cited by 587 · cited 4×
“…et al., 2018; Lebedev et al., 2016; MacLean et al., 2011); (b) mental health and wellbeing (Argento et al., 2017; Bogenschutz et al., 2015; Carhart-Harris et al., 2017, 2018b; Gasser et al., 2015; Griffiths et al., 2006, 2008; Haijen et al., 2018; Hendricks et al., 2015; Johnson et al.,…”
BackgroundInfluentialSelf-citationThe default-mode, ego-functions and free-energy: a neurobiological account of Freudian ideas
Carhart-Harris, R. L., & Friston, K. J. (2010) · Brain · doi:10.1093/brain/awq010 · Cited by 574
Self-citationSerotonin model of schizophrenia: emerging role of glutamate mechanisms
Aghajanian, G. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(99)00046-6 · Cited by 529 · cited 1×
“It seems plausible that a cortical abnormality mediated by increased 5-HT2AR signaling and related glutamatergic activity (Aghajanian and Marek, 2000; Moreno and González-Maeso, 2018) and featuring abnormal plasticity (Kavanagh et al., 2015; Stephan et al., 2009) and associative learning – as…”
BackgroundThe entropic brain - revisited
Carhart-Harris, R. L. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.03.010 · Cited by 522 · cited 5×
“…Ross et al., 2016); (c) political perspective (Lyons and Carhart-Harris, 2018a; Nour et al., 2017); (d) lifestyle preferences (Forstmann and Sagioglou, 2017); and (e) feelings towards the environment/nature (Forstmann and Sagioglou, 2017; Lyons and Carhart-Harris, 2018a; Kettner et al., 2019).”
BackgroundInfluentialSelf-citationGriffiths, R. R., Johnson, M. W., Richards, W. A., Richards, B. D., Jesse, R., MacLean, K. A., Barrett, F. S., Cosimano, M. P., & Klinedinst, M. A. (2018) · Journal of Psychopharmacology · doi:10.1177/0269881117731279 · Cited by 520
Madsen, M. K., Fisher, P. M., Burmester, D., Dyssegaard, A., Stenbæk, D. S., Kristiansen, S., Johansen, S. S., Lehel, S., Linnet, K., Svarer, C., et al. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-019-0324-9 · Cited by 517 · cited 4×
“Selective 5-HT2AR antagonism attenuates the main characteristic subjective effects of LSD, psilocybin and ayahuasca (Preller et al., 2017; Quednow et al., 2012) and the intensity of psychedelic states is reliably predicted by 5-HT2AR occupancy (Madsen et al., 2019).”
BackgroundInfluentialThe social defeat hypothesis of schizophrenia: An update
Selten, J.-P., van der Ven, E., Rutten, B. P. F., & Cantor-Graae, E. (2013) · Schizophrenia Bulletin · doi:10.1093/schbul/sbt134 · Cited by 498 · cited 2×
“…such as unintentional social isolation, urban-environment-related stress, poor socioeconomic status and childhood adversity are likely to mediate and/or potentiate PiMS, and have all been significantly linked with psychotic disorders (Selten and CantorGraae, 2005, 2007; Selten et al., 2013, 2016).”
BackgroundAzmitia, E. C. (2001) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00614-1 · Cited by 497 · cited 1×
“Despite its more modest prevalence in the brain, serotonin neurotransmission is known to play an important modulatory role in several key aspects of mind and behaviour, including brain development (Azmitia, 2001), mood (GarciaGarcia et al., 2017), cognition (Meneses, 1999) and sleep (Jouvet, 1999).”
BackgroundIntolerance of Uncertainty: A Common Factor in the Treatment of Emotional Disorders
Boswell, J. F., Thompson-Hollands, J., Farchione, T. J., & Barlow, D. H. (2013) · Journal of Clinical Psychology · doi:10.1002/jclp.21965 · Cited by 495 · cited 2×
“…2011), namely the proposed (defensive) function of many symptoms of psychopathology may be to mitigate uncertainty through the over-weighting of beliefs and/or excessive reinforcement of certain specific behaviours (Boswell et al., 2013; Carhart-Harris, 2019; CarhartHarris and Friston, 2019).”
BackgroundHartogsohn, I. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116677852 · Cited by 483 · cited 2×
“…often-distressing conditions that naturally agitate the manifestation of a PiMS, psychedelic treatment primes positive transformation via the structuring of ‘set and setting’ (Carhart-Harris et al., 2018c; Hartogsohn, 2016) as part of a broader notion of ‘context’ (Carhart-Harris et al., 2018c).”
BackgroundEgo-dissolution and psychedelics: validation of the ego-dissolution inventory (EDI).
Nour, M. M., Evans, L., Nutt, D., & Carhart-Harris, R. L. (2016) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2016.00269 · Cited by 470 · cited 2×
“All three phenomena are reliably induced by 5-HT2AR agonist psychedelics (Carhart-Harris, 2007; CarhartHarris and Friston, 2010; Kraehenmann et al., 2017; Letheby, 2016; Millière, 2017; Nour et al., 2016), thus implying their relationship to a more fundamental state – the 5-HT2ARR-mediated PiMS.”
BackgroundSelf-citationMoller, P., & Husby, R. (2000) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a033442 · Cited by 464 · cited 1×
“In longer prodromal states, a loss of interest in key activities and pursuits (e.g. education and vocation) and pleasures (e.g. food, sex, social interactions) can coexist with an emerging interest in supernatural paranormal, religious and ritual domains (Møller and Husby, 2000, 2003).”
BackgroundHasler, F., Grimberg, U., Benz, M. A., Huber, T., & Vollenweider, F. X. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1640-6 · Cited by 451
Vollenweider, F. (1997) · Neuropsychopharmacology · doi:10.1016/s0893-133x(96)00246-1 · Cited by 444 · cited 1×
“The psychotomimetic (psychosis-mimicking) effects of classic 5-HT2AR agonist psychedelics have been well documented (Carhart-Harris et al., 2016b; Gonzalez-Maeso and Sealfon, 2009; Quednow et al., 2020; Vollenweider et al., 1997, 1998).”
BackgroundPredicting responses to psychedelics: a prospective study
Haijen, E. C. H. M., Kaelen, M., Roseman, L., Timmermann, C., Kettner, H., Russ, S., Nutt, D., Daws, R. E., Hampshire, A. D. G., Lorenz, R., et al. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00897 · Cited by 417
Self-citationEmotional breakthrough and psychedelics: Validation of the Emotional Breakthrough Inventory
Roseman, L., Haijen, E., Idialu-Ikato, K., Kaelen, M., Watts, R., & Carhart-Harris, R. (2019) · Journal of Psychopharmacology · doi:10.1177/0269881119855974 · Cited by 413 · cited 6×
“…can be found in reports of post-traumatic growth after recovery from psychosis and other severe conditions (Slade et al., 2019), neardeath experiences (Geiger, 2009; Khanna and Greyson, 2015) and in cases of clinical breakthrough with psychedelic therapy (Roseman et al., 2019; Watts et al., 2017).”
BackgroundInfluentialSelf-citationMcEvoy, P. M., & Mahoney, A. E. J. (2011) · Journal of Anxiety Disorders · doi:10.1016/j.janxdis.2010.08.010 · Cited by 412 · cited 2×
“…to perceived uncertainty and loss of control, may be a transdiagnostic feature of psychological suffering (Boswell et al., 2013; Carhart-Harris, 2019; McEvoy and Mahoney, 2011), namely the proposed (defensive) function of many symptoms of psychopathology may be to mitigate uncertainty through the…”
BackgroundPreller, K. H., Herdener, M., Pokorny, T., Planzer, A., Kraehenmann, R., Stämpfli, P., Liechti, M. E., Seifritz, E., & Vollenweider, F. X. (2017) · Current Biology · doi:10.1016/j.cub.2016.12.030 · Cited by 402
Psychedelics, meditation, and self-consciousness
Millière, R., Carhart-Harris, R. L., Roseman, L., Trautwein, F.-M., & Berkovich-Ohana, A. (2018) · Frontiers in Psychology · doi:10.3389/fpsyg.2018.01475 · Cited by 390 · cited 1×
“Achieving the same quality and intensity of experience may be difficult via spiritual practice alone; although a recent study comparing the interaction between psychedelics and meditation has suggested a potential synergistic effect (Smigielski et al., 2019; see also Millière et al., 2018).”
BackgroundSelf-citationPreller, K. H., Burt, J. B., Ji, J. L., Schleifer, C. H., Adkinson, B. D., Stämpfli, P., Seifritz, E., Repovs, G., Krystal, J. H., Murray, J. D., et al. (2018) · eLife · doi:10.7554/elife.35082 · Cited by 390 · cited 1×
“Under psychedelics, the normal functional segregation or specialization in the brain is instead replaced by a globally interconnected profile (Carhart-Harris et al., 2012a, 2016c; Lord et al., 2019; Petri et al., 2014; Preller et al., 2018; Smigielski et al., 2019; Tagliazucchi et al., 2014).”
BackgroundRelational Frame Theory: A Post-Skinnerian Account of Human Language and Cognition
Barnes-Holmes, Y., Hayes, S. C., Barnes-Holmes, D., & Roche, B. (2002) · Advances in Child Development and Behavior · doi:10.1016/s0065-2407(02)80063-5 · Cited by 389
Serotonergic neurons signal reward and punishment on multiple timescales
Cohen, J. Y., Amoroso, M. W., & Uchida, N. (2015) · eLife · doi:10.7554/elife.06346 · Cited by 388
Davis, A. K., Barrett, F. S., & Griffiths, R. R. (2020) · Journal of Contextual Behavioral Science · doi:10.1016/j.jcbs.2019.11.004 · Cited by 375 · cited 1×
“…resilience-related changes (Close et al., 2020; Davis et al., 2019), it is conceivable that psychedelic therapy could be used as a prophylactic or preventative intervention, for example, promoting adaptability in adversity (Close et al., 2020; Davis et al., 2020; Murphy Beiner and Soar, 2020).”
BackgroundEmotions and brain function are altered up to one month after a single high dose of psilocybin.
Barrett, F. S., Doss, M. K., Sepeda, N. D., Pekar, J. J., & Griffiths, R. R. (2020) · Scientific Reports · doi:10.1038/s41598-020-59282-y · Cited by 375 · cited 2×
“…of psilocybin (Olson, 2018), and long-term changes in network functionality have also been observed 1 day (Carhart-Harris et al., 2017), 1 week (Barrett et al., 2020) and 1 month after psilocybin (Lyons, 2020) in clinical (Carhart-Harris et al., 2017) and non-clinical populations…”
BackgroundPrediction of Psilocybin Response in Healthy Volunteers
Studerus, E., Gamma, A., Kometer, M., & Vollenweider, F. X. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030800 · Cited by 369
A High-Resolution In Vivo Atlas of the Human Brain's Serotonin System
Beliveau, V., Ganz, M., Feng, L., Ozenne, B., Højgaard, L., Fisher, P. M., Svarer, C., Greve, D. N., & Knudsen, G. M. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.2830-16.2016 · Cited by 368
Barrett, F. S., Bradstreet, M. P., Leoutsakos, J.-M. S., Johnson, M. W., & Griffiths, R. R. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116678781 · Cited by 366 · cited 3×
“…elevated cortical 5-HT2AR expression (Frokjaer et al., 2008), predicts thought disturbance, blackout and challenging experiences under psychedelics (Barrett et al., 2016, 2017; Lienert and Netter, 1996; although see Studerus et al., 2012) and yet may be reduced after psychedelic therapy (Erritzoe…”
BackgroundPsychiatry & the psychedelic drugs. Past, present & future
Rucker, J. J. H., Iliff, J., & Nutt, D. J. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.12.040 · Cited by 343 · cited 1×
“It is also consistent with a growing literature base supporting the value of classic (5-HT2AR agonist) psychedelic therapy in the treatment of a broad range of psychiatric disorders (Carhart-Harris and Goodwin, 2017; Nutt et al., 2020; Rucker et al., 2018).”
ResultFinding the self by losing the self: neural correlates of ego-dissolution under psilocybin
Lebedev, A. V., Lövdén, M., Rosenthal, G., Feilding, A., Nutt, D. J., & Carhart-Harris, R. L. (2015) · Human Brain Mapping · doi:10.1002/hbm.22833 · Cited by 339 · cited 2×
“…the acute psychedelic state using a variety of psychedelics have observed decreases in the functional modularity of a broad range of functional modules, including high-level networks such as the default-mode and fronto-parietal control network (Carhart-Harris et al., 2016c; Lebedev et al., 2015).”
BackgroundSelf-citationLSD enhances suggestibility in healthy volunteers
Carhart-Harris, R. L., Kaelen, M., Whalley, M. G., Bolstridge, M., Feilding, A., & Nutt, D. J. (2015) · Psychopharmacology · doi:10.1007/s00213-014-3714-z · Cited by 320 · cited 3×
“Beyond the hypothesized involvement of the 5-HT2AR in the induction of psychotic states (Carhart-Harris et al., 2014b; Geyer and Vollenweider, 2008), it is generally thought that dopaminergic (DA) dysregulation serves as a ‘final common pathway’ underlying chronic psychoses (Howes and Kapur, 2009).”
BackgroundSelf-citationBelser, A. B., Agin-Liebes, G., Swift, T. C., Terrana, S., Devenot, N., Friedman, H. L., Guss, J., Bossis, A., & Ross, S. (2017) · Journal of Humanistic Psychology · doi:10.1177/0022167817706884 · Cited by 311 · cited 3×
“Values can be ‘remembered’ (Belser et al., 2017) and affect-laden beliefs that previously seemed ‘abstract’ (e.g. ‘love is fundamental’) can be deeply felt (Belser et al., 2017; Pollan, 2019).”
BackgroundLSD‐induced entropic brain activity predicts subsequent personality change
Lebedev, A. V., Kaelen, M., Lövdén, M., Nilsson, J., Feilding, A., Nutt, D. J., & Carhart‐Harris, R. L. (2016) · Human Brain Mapping · doi:10.1002/hbm.23234 · Cited by 303
Self-citationThe paradoxical psychological effects of lysergic acid diethylamide LSD
Carhart-Harris, R. L., Kaelen, M., Bolstridge, M., Williams, T. M., Williams, L. T., Underwood, R., Feilding, A., & Nutt, D. J. (2016) · Psychological Medicine · doi:10.1017/s0033291715002901 · Cited by 293 · cited 7×
“Under psychedelics, the normal functional segregation or specialization in the brain is instead replaced by a globally interconnected profile (Carhart-Harris et al., 2012a, 2016c; Lord et al., 2019; Petri et al., 2014; Preller et al., 2018; Smigielski et al., 2019; Tagliazucchi et al., 2014).”
BackgroundInfluentialSelf-citationGrubaugh, A. L., Zinzow, H. M., Paul, L., Egede, L. E., & Frueh, B. C. (2011) · Clinical Psychology Review · doi:10.1016/j.cpr.2011.04.003 · Cited by 287 · cited 1×
“There exists an especially high comorbidity between psychotic and PTSD symptoms (Grubaugh et al., 2011; Ng et al., 2016).”
BackgroundClassic Hallucinogens and Mystical Experiences: Phenomenology and Neural Correlates
Barrett, F. S., & Griffiths, R. R. (2017) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2017_474 · Cited by 273
Psychedelics as anti-inflammatory agents
Flanagan, T. W., & Nichols, C. D. (2018) · International Review of Psychiatry · doi:10.1080/09540261.2018.1481827 · Cited by 267 · cited 2×
“…activation has neuroprotective and antiinflammatory effects (Billac and Nichols, 2019; Fanibunda et al., 2019; Flanagan et al., 2019a, 2019b; Flanagan and Nichols, 2018; Nau et al., 2013; Yu et al., 2008) and inflammation is a common feature of stress-related disorders (Liu et al., 2017)…”
BackgroundEffects of psilocybin therapy on personality structure
Erritzoe, D., Roseman, L., Nour, M. M., MacLean, K., Kaelen, M., Nutt, D. J., & Carhart‐Harris, R. L. (2018) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12904 · Cited by 267
Self-citationEffects of psilocybin on hippocampal neurogenesis and extinction of trace fear conditioning
Catlow, B. J., Song, S., Paredes, D. A., Kirstein, C. L., & Sanchez-Ramos, J. (2013) · Experimental Brain Research · doi:10.1007/s00221-013-3579-0 · Cited by 266 · cited 1×
“Psychedelics have been shown to promote extinction-learning through 5-HT2AR agonism (Cameron et al., 2018; Catlow et al., 2013; Young et al., 2017) as well as low-level associative learning (Gimpl et al., 1979; Harvey, 1996, 2003; King et al., 1974; Morici et al., 2018; Romano et al., 2010; Welsh…”
BackgroundPsychedelics and connectedness
Carhart-Harris, R. L., Erritzoe, D., Haijen, E., Kaelen, M., & Watts, R. (2018) · Psychopharmacology · doi:10.1007/s00213-017-4701-y · Cited by 265
Self-citationDysfunctional Attitudes and 5-HT2 Receptors During Depression and Self-Harm
Meyer, J. H., McMain, S., Kennedy, S. H., Korman, L., Brown, G. M., DaSilva, J. N., Wilson, A. A., Blak, T., Eynan-Harvey, R., Goulding, V. S., et al. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.1.90 · Cited by 264 · cited 2×
“…5-HT2AR transcript and protein expression in neuroticism (Frokjaer et al., 2008) and depression (Amidfar et al., 2017; Bhagwagar et al., 2006; Meyer et al., 2003; Shelton et al., 2009; although see Steinberg et al., 2019), particularly in relationship to dysfunctional attitudes (Baeken et…”
BackgroundPsychoplastogens: A promising class of plasticity-promoting neurotherapeutics
Olson, D. E. (2018) · Journal of Experimental Neuroscience · doi:10.1177/1179069518800508 · Cited by 257 · cited 4×
“We have preliminary evidence of increased visual evoked long-term potentiation (LTP) in healthy individuals under the influence of psilocybin (Olson, 2018), and long-term changes in network functionality have also been observed 1 day (Carhart-Harris et al., 2017), 1 week (Barrett et al., 2020) and…”
BackgroundInfluentialFunctional Connectivity Measures After Psilocybin Inform a Novel Hypothesis of Early Psychosis
Carhart-Harris, R. L., Leech, R., Erritzoe, D., Williams, T. M., Stone, J. M., Evans, J., Sharp, D. J., Feilding, A., Wise, R. G., & Nutt, D. J. (2013) · Schizophrenia Bulletin · doi:10.1093/schbul/sbs117 · Cited by 256 · cited 4×
“Under psychedelics, the normal functional segregation or specialization in the brain is instead replaced by a globally interconnected profile (Carhart-Harris et al., 2012a, 2016c; Lord et al., 2019; Petri et al., 2014; Preller et al., 2018; Smigielski et al., 2019; Tagliazucchi et al., 2014).”
BackgroundResultInfluentialSelf-citationSmigielski, L., Scheidegger, M., Kometer, M., & Vollenweider, F. X. (2019) · NeuroImage · doi:10.1016/j.neuroimage.2019.04.009 · Cited by 248 · cited 2×
“Under psychedelics, the normal functional segregation or specialization in the brain is instead replaced by a globally interconnected profile (Carhart-Harris et al., 2012a, 2016c; Lord et al., 2019; Petri et al., 2014; Preller et al., 2018; Smigielski et al., 2019; Tagliazucchi et al., 2014).”
BackgroundExperiential Avoidance: An Examination of the Construct Validity of the AAQ-II and MEAQ
Rochefort, C., Baldwin, A. S., & Chmielewski, M. (2018) · Behavior Therapy · doi:10.1016/j.beth.2017.08.008 · Cited by 247 · cited 1×
“Themes of psychological flexibility (Zhang et al., 2018) and experiential acceptance (Rochefort et al., 2018; Watts et al., 2017) are also relevant here.”
BackgroundLSD Acutely Impairs Fear Recognition and Enhances Emotional Empathy and Sociality
Dolder, P. C., Schmid, Y., Müller, F., Borgwardt, S., & Liechti, M. E. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.82 · Cited by 247 · cited 1×
“In therapeutic contexts, this experience is generally positive and is associated with an enhanced sense of emotional empathy (Dolder et al., 2016; Pokorny et al., 2017) and prosocial feelings and behaviour (Griffiths et al., 2018).”
BackgroundLiechti, M. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00126-3 · Cited by 245 · cited 1×
“…an appreciable increase in activity at the 5-HT2AR through its potent release of 5-HT (van Wel et al., 2012), the nonspecific nature of MDMA’s pro-serotonergic, and indeed noradrenergic and DA effects, complicates our understanding of its (pharmaco)therapeutic mechanisms (Liechti et al., 2000).”
BackgroundFrokjaer, V. G., Mortensen, E. L., Nielsen, F. Å., Haugbol, S., Pinborg, L. H., Adams, K. H., Svarer, C., Hasselbalch, S. G., Holm, S., Paulson, O. B., et al. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.07.009 · Cited by 242 · cited 2×
“Consistent with the PiMS model, baseline neuroticism is associated with elevated cortical 5-HT2AR expression (Frokjaer et al., 2008), predicts thought disturbance, blackout and challenging experiences under psychedelics (Barrett et al., 2016, 2017; Lienert and Netter, 1996; although see Studerus et…”
Activity patterns of serotonin neurons underlying cognitive flexibility
Matias, S., Lottem, E., Dugué, G. P., & Mainen, Z. F. (2017) · eLife · doi:10.7554/elife.20552 · Cited by 239 · cited 1×
“…piece on 5-HT2AR-mediated ‘active coping’ and radical adaptation proposed by CarhartHarris and Nutt (2017), as well as animal work linking serotonergic functioning to faster learning rates (Harvey, 2003; Iigaya et al., 2018), plasticity (Iigaya et al., 2018) and adaptability (Matias et al., 2017).”
BackgroundTedeschi, R. G. (1999) · Aggression and Violent Behavior · doi:10.1016/s1359-1789(98)00005-6 · Cited by 236 · cited 2×
“The same functional explanation could also be used in reference to ‘post-traumatic growth’, a construct that, at least by name, is only two decades old (Tedeschi, 1999).”
BackgroundJauhar, S., Nour, M. M., Veronese, M., Rogdaki, M., Bonoldi, I., Azis, M., Turkheimer, F., McGuire, P., Young, A. H., & Howes, O. D. (2017) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2017.2943 · Cited by 233 · cited 1×
“Indeed, manic states might precipitate incipient psychoses in a similar fashion (Correll et al., 2007; Jauhar et al., 2017).”
ResultThe antipodes Of the mind: Charting the Phenomenology of the Ayahuasca Experience
Shanon, B. (2002) · doi:10.1093/oso/9780199252923.001.0001 · Cited by 232
Rapid modulation of spine morphology by the 5-HT 2A serotonin receptor through kalirin-7 signaling
Jones, K. A., Srivastava, D. P., Allen, J. A., Strachan, R. T., Roth, B. L., & Penzes, P. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905884106 · Cited by 226 · cited 1×
“Consistently, psychedelics have been shown to potently increase cortical neuroplasticity (Benekareddy et al., 2012; Cavus and Duman, 2003; Frankel and Cunningham, 2002; Gewirtz et al., 2002; Jaggar and Vaidya, 2018; Jones et al., 2009; Meller et al., 2002; Niitsu et al., 1995; Vaidya et al., 1997).”
BackgroundClassic hallucinogens in the treatment of addictions
Bogenschutz, M. P., & Johnson, M. W. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.03.002 · Cited by 226 · cited 1×
“Clinically supervised psychedelic experiences are showing promise for the alleviation of a large number of psychiatric symptoms and unhealthy lifestyle habits (Bogenschutz and Johnson, 2016; Carhart-Harris et al., 2018a; Carhart-Harris and Goodwin, 2017; Johnson, 2018).”
BackgroundPsychedelics, personality and political perspectives.
Nour, M. M., Evans, L., & Carhart-Harris, R. L. (2017) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2017.1312643 · Cited by 226
Self-citationNeural correlates of nondual awareness in meditation
Josipovic, Z. (2014) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12261 · Cited by 226
Boulougouris, V., Glennon, J. C., & Robbins, T. W. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301584 · Cited by 219 · cited 2×
“…styles (Boulougouris et al., 2008; King et al., 1974; MurphyBeiner and Soar, 2020) might fit with an initial serotonergic (5-HT2AR) component (although see Boulougouris et al., 2008), followed by a final pathway that is dominated by a hyperactive mesolimbic dopamine system (Stahl, 2018).”
BackgroundCraddock, N., O'Donovan, M. C., & Owen, M. J. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp020 · Cited by 216 · cited 1×
“Comorbidity of bipolar, schizophrenia and schizoaffective disorders reflects a shared polygenic vulnerability to psychotic symptoms (Cardno and Owen, 2014; Craddock et al., 2009; Laursen et al., 2009) and possibly, by extension, PiMSs.”
BackgroundSchlosser, M., Sparby, T., Vörös, S., Jones, R., & Marchant, N. L. (2019) · PLOS ONE · doi:10.1371/journal.pone.0216643 · Cited by 209 · cited 1×
“…is highly relevant to inappropriate and/or unsupported psychedelic drug use, as well as malpractice in any kind of paediatric, pastoral or healthcare sector where individuals exhibiting elevated brain plasticity are implicated (Carhart-Harris et al., 2018c; Kornfield, 2001; Schlosser et al., 2019).”
BackgroundMillière, R. (2017) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2017.00245 · Cited by 206 · cited 5×
“All three phenomena are reliably induced by 5-HT2AR agonist psychedelics (Carhart-Harris, 2007; CarhartHarris and Friston, 2010; Kraehenmann et al., 2017; Letheby, 2016; Millière, 2017; Nour et al., 2016), thus implying their relationship to a more fundamental state – the 5-HT2ARR-mediated PiMS.”
BackgroundInfluentialDelusion formation and reasoning biases in those at clinical high risk for psychosis
Broome, M. R., Johns, L. C., Valli, I., Woolley, J. B., Tabraham, P., Brett, C., Valmaggia, L., Peters, E., Garety, P. A., & McGuire, P. K. (2007) · British Journal of Psychiatry · doi:10.1192/bjp.191.51.s38 · Cited by 204 · cited 1×
“…but the same mechanisms could just as easily result in a new or reinforced maladaptive strategy, perhaps best exemplified by a psychotic ‘flight from reality’ (Broome et al., 2007; Freeman et al., 2014; Lyon et al., 1994) or progressive reinforcement of other psychological defence mechanisms.”
BackgroundAcceptance and Commitment Therapy for Health Behavior Change: A Contextually-Driven Approach
Zhang, C.-Q., Leeming, E., Smith, P., Chung, P.-K., Hagger, M. S., & Hayes, S. C. (2018) · Frontiers in Psychology · doi:10.3389/fpsyg.2017.02350 · Cited by 199 · cited 1×
“Themes of psychological flexibility (Zhang et al., 2018) and experiential acceptance (Rochefort et al., 2018; Watts et al., 2017) are also relevant here.”
BackgroundAlterations of consciousness and mystical-type experiences after acute LSD in humans
Liechti, M. E., Dolder, P. C., & Schmid, Y. (2017) · Psychopharmacology · doi:10.1007/s00213-016-4453-0 · Cited by 198
Virtual reality and consciousness inference in dreaming
Hobson, J. A., Hong, C. C.-H., & Friston, K. J. (2014) · Frontiers in Psychology · doi:10.3389/fpsyg.2014.01133 · Cited by 197 · cited 1×
“Other states we could have looked at in relation to PiMSs include REM sleep (Carhart-Harris, 2007; CarhartHarris and Nutt, 2014; Hobson et al., 2014; McNamara, 2016; Sanz et al., 2018), particularly given its phenomenological qualities (McNamara, 2019), sensitivity to 5-HT2AR manipulation (Monti et…”
BackgroundEffect of Psilocybin on Empathy and Moral Decision-Making
Pokorny, T., Preller, K. H., Kometer, M., Dziobek, I., & Vollenweider, F. X. (2017) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyx047 · Cited by 197 · cited 1×
“In therapeutic contexts, this experience is generally positive and is associated with an enhanced sense of emotional empathy (Dolder et al., 2016; Pokorny et al., 2017) and prosocial feelings and behaviour (Griffiths et al., 2018).”
BackgroundAm i self-conscious? (or does self-organization entail self-consciousness?)
Friston, K. (2018) · Frontiers in Psychology · doi:10.3389/fpsyg.2018.00579 · Cited by 197 · cited 1×
“…and function appears to be organized hierarchically (Felleman and Van, 1991; Margulies et al., 2016) and it is proposed that relevant predictive mechanisms are encoded in the brain’s multi-level functional and anatomical hierarchies (Clark, 2013; Friston, 2018; Rao and Ballard, 1999; Seth, 2013).”
BackgroundEpigenetic dysregulation of HTR2A in the brain of patients with schizophrenia and bipolar disorder
Abdolmaleky, H. M., Yaqubi, S., Papageorgis, P., Lambert, A. W., Ozturk, S., Sivaraman, V., & Thiagalingam, S. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.04.007 · Cited by 192
Awe in nature heals: evidence from military veterans, at-risk youth, and college students
Anderson, C. L., Monroy, M., & Keltner, D. (2018) · Emotion · doi:10.1037/emo0000442 · Cited by 191
Madsen, M. K., Fisher, P. M., Stenbæk, D. S., Kristiansen, S., Burmester, D., Lehel, S., Páleníček, T., Kuchař, M., Svarer, C., Ozenne, B., et al. (2020) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2020.02.001 · Cited by 183 · cited 1×
“Indeed, agonist-induced downregulation of the 5-HT2AR is entirely consistent with this principle (Bull et al., 2004; Erritzoe et al., 2011; Muguruza et al., 2014; Reneman et al., 2002; also see Madsen et al., 2020).”
ResultSleep disorders in early psychosis: incidence, severity, and association with clinical symptoms
Reeve, S., Sheaves, B., & Freeman, D. (2019) · Schizophrenia Bulletin · doi:10.1093/schbul/sby129 · Cited by 182 · cited 1×
“Sleep deprivation can serve as a model of psychosis and the relationship between sleep deprivation/disorders and psychosis is well established (Meyhöfer et al., 2017; Reeve et al., 2018; Waters et al., 2018).”
BackgroundSloshower, J., Guss, J., Krause, R., Wallace, R. M., Williams, M. T., Reed, S., & Skinta, M. D. (2020) · Journal of Contextual Behavioral Science · doi:10.1016/j.jcbs.2019.11.002 · Cited by 171
Effects of N,N-Dimethyltryptamine on Rat Behaviors Relevant to Anxiety and Depression
Cameron, L. P., Benson, C. J., Dunlap, L. E., & Olson, D. E. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00134 · Cited by 171
Early life experience alters behavior during social defeat: Focus on serotonergic systems
Gardner, K. L., Thrivikraman, K. V., Lightman, S. L., Plotsky, P. M., & Lowry, C. A. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.07.042 · Cited by 169 · cited 2×
“Acute social defeat increases 5-HT levels (Beitia et al., 2005; Gardner et al., 2005; Higuchi et al., 2019; Keeney et al., 2006; Paul et al., 2011), and region-specific increases in 5-HT2AR expression have been found in chronically subordinate animals (Berton et al., 1997; McKittrick et al., 1995).”
BackgroundSerotonergic regulation of neuronal excitability in the prefrontal cortex
Andrade, R. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.01.015 · Cited by 167 · cited 1×
“Serotonin is a particularly complex neuromodulator, with a broad range of receptor subtypes (i.e. at least 14 different subtypes have been identified to date (Hoyer, 2019), some of which have opposing functions on activation (Andrade, 2011; Araneda and Andrade, 1991)).”
BackgroundWaters, F., Chiu, V., Atkinson, A., & Blom, J. D. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00303 · Cited by 165
Kuijpers, H. J. H., van der Heijden, F. M. M. A., Tuinier, S., & Verhoeven, W. M. A. (2007) · Psychopathology · doi:10.1159/000108125 · Cited by 164 · cited 2×
“…on the function of 5-HT2AR signaling, including how it relates to mental illness and its treatment, such as via psychedelic therapy (Carhart-Harris and Goodwin, 2017), plus other methods of manipulating PiMSs for psychotherapeutic ends (Fosha, 2000; Grof and Grof, 2010; Kuijpers et al., 2007).”
BackgroundMethodThe role of serotonin in the regulation of patience and impulsivity
Miyazaki, K., Miyazaki, K. W., & Doya, K. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8232-6 · Cited by 162 · cited 1×
“…in moderating anxiety states (Charney et al., 1987; Deakin and Graeff, 1991; Piszczek et al., 2015) as well as impulsivity/impatience and aggression (Brown and Linnoila, 1990; Fairbanks et al., 2001; Fonseca et al., 2015; McDannald, 2015; Miyazaki et al., 2012, 2014, 2018; Ranade et al., 2014).”
BackgroundExaggerated 5-HT1A but Normal 5-HT2A Receptor Activity in Individuals Ill with Anorexia Nervosa
Bailer, U. F., Frank, G. K., Henry, S. E., Price, J. C., Meltzer, C. C., Mathis, C. A., Wagner, A., Thornton, L., Hoge, J., Ziolko, S. K., et al. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.07.018 · Cited by 161 · cited 1×
“…of increased 5-HT2AR expression in overweight individuals (Erritzoe et al., 2008; although see Chaouloff et al., 1995) and reduced 5-HT2AR expression in anorexia nervosa (AN) (Audenaert et al., 2003; Bailer et al., 2004; Frank et al., 2002; Kaye et al., 2013; although see Bailer et al., 2007).”
BackgroundAbsorption and spiritual experience: a review of evidence and potential mechanisms
Lifshitz, M., van Elk, M., & Luhrmann, T. M. (2019) · Consciousness and Cognition · doi:10.1016/j.concog.2019.05.008 · Cited by 160
Effects of Anxiety on Spontaneous Ritualized Behavior
Lang, M., Krátký, J., Shaver, J. H., Jerotijević, D., & Xygalatas, D. (2015) · Current Biology · doi:10.1016/j.cub.2015.05.049 · Cited by 158
Bland, S. T., Hargrave, D., Pepin, J. L., Amat, J., Watkins, L. R., & Maier, S. F. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300206 · Cited by 155 · cited 3×
“In relation to naturally occurring PiMSs, both uncontrollable stress (Amat et al., 2005; Bland et al., 2003) and punishment (Cohen et al., 2015; Faulkner and Deakin, 2014) are associated with 5-HT release (Amat et al., 2005; Bland et al., 2003; Cohen et al., 2015; Faulkner and Deakin, 2014).”
BackgroundPrediction error, ketamine and psychosis: An updated model
Corlett, P. R., Honey, G. D., & Fletcher, P. C. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116650087 · Cited by 142 · cited 1×
“We acknowledge that other neurotransmitters such as noradrenaline and acetylcholine (Angela and Dayan, 2005), glutamate (Corlett et al., 2016), dopamine (Howes and Kapur, 2009) as well as the endocannabinoid (Ibarra-Lecue et al., 2018) and opiate systems (Butelman and Kreek, 2015) will likely play…”
BackgroundA review of 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy
Sessa, B., Higbed, L., & Nutt, D. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00138 · Cited by 141 · cited 1×
“Like the classic psychedelics, MDMA and ketamine have both been used as adjuncts to psychotherapy, with notable success (McGirr et al., 2017; Sessa et al., 2019; Wilkinson et al., 2017).”
BackgroundPharmacology of ayahuasca administered in two repeated doses
dos Santos, R. G., Grasa, E., Valle, M., Ballester, M. R., Bouso, J. C., Nomdedéu, J. F., Homs, R., Barbanoj, M. J., & Riba, J. (2012) · Psychopharmacology · doi:10.1007/s00213-011-2434-x · Cited by 141 · cited 1×
“Psychedelics have also been shown to increase the release of stress hormones (Alper, 1990; Calogero et al., 1989; Dos Santos et al., 2012; Hasler et al., 2004; Owens et al., 1991; Schmid et al., 2015; Strajhar et al., 2016; see Schindler et al., 2018 for review).”
BackgroundPsychotherapy with lysergic acid diethylamide
EISNER, B. G., & COHEN, S. (1958) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-195812000-00006 · Cited by 138
Ayahuasca’s ‘afterglow’: improved mindfulness and cognitive flexibility in ayahuasca drinkers
Murphy-Beiner, A., & Soar, K. (2020) · Psychopharmacology · doi:10.1007/s00213-019-05445-3 · Cited by 135
Brain Neuroplasticity in Healthy, Hyperactive and Psychotic Children: Insights from Neuroimaging
Rapoport, J. L., & Gogtay, N. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301553 · Cited by 132
Sadzot, B., Baraban, J. M., Glennon, R. A., Lyon, R. A., Leonhardt, S., Jan, C.-R., & Titeler, M. (1989) · Psychopharmacology · doi:10.1007/bf00441948 · Cited by 132
Parnas, J., & Henriksen, M. G. (2016) · Consciousness and Cognition · doi:10.1016/j.concog.2016.05.010 · Cited by 132
Individual experiences in four cancer patients following psilocybin-assisted psychotherapy
Malone, T. C., Mennenga, S. E., Guss, J., Podrebarac, S. K., Owens, L. T., Bossis, A. P., Belser, A. B., Agin-Liebes, G., Bogenschutz, M. P., & Ross, S. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00256 · Cited by 131 · cited 1×
“…during and after psychedelic experiences (Barrett et al., 2016; Belser et al., 2017; Carbonaro et al., 2016; Eisner and Cohen, 1958; Gasser et al., 2015; Roseman et al., 2018, 2019) as are symbolic/archetypal themes (Hill, 2013; Malone et al., 2018; Masters and Houston, 2000 [1966]; Shanon, 2002).”
BackgroundSzabo, A., Kovacs, A., Riba, J., Djurovic, S., Rajnavolgyi, E., & Frecska, E. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00423 · Cited by 121
Iigaya, K., Fonseca, M. S., Murakami, M., Mainen, Z. F., & Dayan, P. (2018) · Nature Communications · doi:10.1038/s41467-018-04840-2 · Cited by 120 · cited 1×
“…piece on 5-HT2AR-mediated ‘active coping’ and radical adaptation proposed by CarhartHarris and Nutt (2017), as well as animal work linking serotonergic functioning to faster learning rates (Harvey, 2003; Iigaya et al., 2018), plasticity (Iigaya et al., 2018) and adaptability (Matias et al., 2017).”
BackgroundREM Sleep Rebound as an Adaptive Response to Stressful Situations
Suchecki, D., Tiba, P. A., & Machado, R. B. (2012) · Frontiers in Neurology · doi:10.3389/fneur.2012.00041 · Cited by 119
Young, M. B., Norrholm, S. D., Khoury, L. M., Jovanovic, T., Rauch, S. A. M., Reiff, C. M., Dunlop, B. W., Rothbaum, B. O., & Howell, L. L. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4684-8 · Cited by 108 · cited 1×
“Psychedelics have been shown to promote extinction-learning through 5-HT2AR agonism (Cameron et al., 2018; Catlow et al., 2013; Young et al., 2017) as well as low-level associative learning (Gimpl et al., 1979; Harvey, 1996, 2003; King et al., 1974; Morici et al., 2018; Romano et al., 2010; Welsh…”
BackgroundCarhart-Harris, R. L., Wall, M. B., Erritzoe, D., Kaelen, M., Ferguson, B., De Meer, I., Tanner, M., Bloomfield, M., Williams, T. M., Bolstridge, M., et al. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713001405 · Cited by 108 · cited 3×
“Beyond the hypothesized involvement of the 5-HT2AR in the induction of psychotic states (Carhart-Harris et al., 2014b; Geyer and Vollenweider, 2008), it is generally thought that dopaminergic (DA) dysregulation serves as a ‘final common pathway’ underlying chronic psychoses (Howes and Kapur, 2009).”
BackgroundSelf-citationBiosynthesis and Extracellular Concentrations of N,N-dimethyltryptamine (DMT) in Mammalian Brain
Dean, J. G., Liu, T., Huff, S., Sheler, B., Barker, S. A., Strassman, R. J., Wang, M. M., & Borjigin, J. (2019) · Scientific Reports · doi:10.1038/s41598-019-45812-w · Cited by 107
Eyssel, F., & Reich, N. (2013) · 2013 8th ACM/IEEE International Conference on Human-Robot Interaction (HRI) · doi:10.1109/hri.2013.6483531 · Cited by 101 · cited 1×
“…sensed presence (Geiger, 2009; Steffen and Coyle, 2010), and loneliness has also been linked with facets of magical thinking such as anthropomorphization (Bartz et al., 2016; Epley et al., 2008; Eyssel and Reich, 2013), which is a feature of religious belief (Guthrie and Guthrie, 1995).”
BackgroundNeuroticism is associated with challenging experiences with psilocybin mushrooms
Barrett, F. S., Johnson, M. W., & Griffiths, R. R. (2017) · Personality and Individual Differences · doi:10.1016/j.paid.2017.06.004 · Cited by 98 · cited 1×
“…elevated cortical 5-HT2AR expression (Frokjaer et al., 2008), predicts thought disturbance, blackout and challenging experiences under psychedelics (Barrett et al., 2016, 2017; Lienert and Netter, 1996; although see Studerus et al., 2012) and yet may be reduced after psychedelic therapy (Erritzoe…”
BackgroundDMT alters cortical travelling waves
Alamia, A., Timmermann, C., Nutt, D. J., VanRullen, R., & Carhart-Harris, R. L. (2020) · eLife · doi:10.7554/elife.59784 · Cited by 97
Self-citation“Spiritual but not religious”: Cognition, schizotypy, and conversion in alternative beliefs
Willard, A. K., & Norenzayan, A. (2017) · Cognition · doi:10.1016/j.cognition.2017.05.018 · Cited by 95
Dreams and Psychedelics: Neurophenomenological Comparison and Therapeutic Implications
Kraehenmann, R. (2017) · Current Neuropharmacology · doi:10.2174/1573413713666170619092629 · Cited by 92 · cited 1×
“…manipulation (Monti et al., 2018; Monti and Jantos, 2006), evidence for its role in processing stressful scenarios (Suchecki et al., 2012) and similarities between its neural correlates and those of the psychedelic state (Carhart-Harris, 2007; Carhart-Harris and Nutt, 2014; Kraehenmann, 2017).”
BackgroundJackson, M. (1997) · Schizotypy · doi:10.1093/med:psych/9780198523536.003.0011 · Cited by 90 · cited 2×
“According to the model presented here, the framing of psychosis as pathological and spiritual experience as psychologically beneficial, obscures their common relationship to the PiMS (Jackson, 1997).”
BackgroundFujino, K., Yoshitake, T., Inoue, O., Ibii, N., Kehr, J., Ishida, J., Nohta, H., & Yamaguchi, M. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00029-0 · Cited by 86
More Realistic Forecasting of Future Life Events After Psilocybin for Treatment-Resistant Depression
Lyons, T., & Carhart-Harris, R. L. (2018) · Frontiers in Psychology · doi:10.3389/fpsyg.2018.01721 · Cited by 77
Self-citationBrain monoamine receptors in a chronic unpredictable stress model in rats
Ossowska, G., Nowak, G., Kata, R., Klenk-Majewska, B., Danilczuk, Z., & Żebrowska-Łupina, I. (2001) · Journal of Neural Transmission · doi:10.1007/s007020170077 · Cited by 76
Positive psychology in the investigation of psychedelics and entactogens: a critical review
Jungaberle, H., Thal, S., Zeuch, A., Rougemont-Bücking, A., von Heyden, M., Aicher, H., & Scheidegger, M. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.06.034 · Cited by 70 · cited 1×
“For example, given observed improvements in psychological wellbeing (Jungaberle et al., 2018; Walsh, 1982) including resilience-related changes (Close et al., 2020; Davis et al., 2019), it is conceivable that psychedelic therapy could be used as a prophylactic or preventative intervention, for…”
BackgroundProlonged maternal separation disturbs the serotonergic system during early brain development
Ohta, K., Miki, T., Warita, K., Suzuki, S., Kusaka, T., Yakura, T., Liu, J., Tamai, M., & Takeuchi, Y. (2014) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2013.10.007 · Cited by 68
The epistemic innocence of psychedelic states
Letheby, C. (2016) · Consciousness and Cognition · doi:10.1016/j.concog.2015.11.012 · Cited by 67 · cited 2×
“One should therefore be mindful of potential risks entailed by destabilizing such beliefs, either via the direct action of psychedelic drugs or other means; see Letheby (2016) for a relevant discussion paper.”
BackgroundHolotropic Breathwork: A New Approach to Self-Exploration and Therapy
Grof, S., Grof, C., & Kornfield, J. (2010) · doi:10.1515/9781438433950 · Cited by 64
Menon, J. M. L., Nolten, C., Achterberg, E. J. M., Joosten, R. N. J. M. A., Dematteis, M., Feenstra, M. G. P., Drinkenburg, W. H. (., & Leenaars, C. H. C. (2019) · Journal of Circadian Rhythms · doi:10.5334/jcr.174 · Cited by 57 · cited 1×
“…respectively (see Monti et al., 2018 for review), and both increases and decreases in 5-HT levels following sleep deprivation have been observed (see Menon et al., 2019 for review), although increased 5-HT levels may be more likely if combined with malnourishment (Alfaro-Rodríguez et al., 2006).”
BackgroundObstructive sleep apnoea and schizophrenia — A research agenda
Kalucy, M. J., Grunstein, R., Lambert, T., & Glozier, N. (2013) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2012.10.003 · Cited by 55
Close, J. B., Hajien, E. C., Watts, R., Roseman, L., & Carhart-Harris, R. L. (2020) · Journal of Contextual Behavioral Science · doi:10.1016/j.jcbs.2020.01.005 · Cited by 54
Self-citationDelusional themes across affective and non-affective psychoses
Picardi, A., Fonzi, L., Pallagrosi, M., Gigantesco, A., & Biondi, M. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00132 · Cited by 50
Cheah, S.-Y., Lawford, B., Young, R., Morris, C., & Voisey, J. (2017) · Genes · doi:10.3390/genes8010014 · Cited by 50
Zhang, G., Cinalli, D., Cohen, S. J., Knapp, K. D., Rios, L. M., Martínez-Hernández, J., Luján, R., & Stackman, R. W. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.04.033 · Cited by 41
Visionary Spiritual Experiences
Lukoff, D. (2007) · Southern Medical Journal · doi:10.1097/smj.0b013e318060072f · Cited by 40 · cited 1×
“…2016; Buckley, 1981; Cangas et al., 2008; Crespi et al., 2019; Grof and Grof, 1989; Hunt, 2000, 2007; Jackson, 1997; Jaynes, 1976; Luhrmann, 2017; Lukoff, 1985, 2007, 2018; Murray et al., 2012; Parnas and Henriksen, 2016; Perry, 1977; Polimeni, 2018; Powers and Corlett, 2018; Ross and McKay,…”
Xu, C., Ma, X.-M., Chen, H.-B., Zhou, M.-H., Qiao, H., & An, S.-C. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.02.020 · Cited by 34
Godar, S. C., Mosher, L. J., Scheggi, S., Devoto, P., Moench, K. M., Strathman, H. J., Jones, C. M., Frau, R., Melis, M., Gambarana, C., et al. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.01.028 · Cited by 33 · cited 4×
“Preliminary evidence also suggests that maternal separation upregulates 5-HT2ARs (Godar et al., 2019) and 5-HT2AR mRNA expression (Benekareddy et al., 2011; Vazquez et al., 2000; although see Ohta et al., 2014).”
BackgroundInfluentialSood, A., Pati, S., Bhattacharya, A., Chaudhari, K., & Vaidya, V. A. (2018) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2017.10.005 · Cited by 25 · cited 2×
“Social isolation and defeat also reliably sensitize behavioural responses to 5-HT2AR agonists (Benekareddy et al., 2010; Brotto et al., 1998; Gorzalka et al., 1998; Sakaue et al., 2002; Sood et al., 2018; Wright et al., 1991; see also Table 1).”
BackgroundNg, L. C., Petruzzi, L. J., Greene, M. C., Mueser, K. T., Borba, C. P. C., & Henderson, D. C. (2016) · Journal of Nervous & Mental Disease · doi:10.1097/nmd.0000000000000523 · Cited by 17 · cited 1×
“There exists an especially high comorbidity between psychotic and PTSD symptoms (Grubaugh et al., 2011; Ng et al., 2016).”
BackgroundZuo, W., Wu, L., Mei, Q., Zuo, Q., Zhou, Z., Fu, R., Li, W., Wu, W., Matthew, L., & Ye, J.-H. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.107747 · Cited by 17
Cited by
Trial of Psilocybin versus Escitalopram for Depression
Carhart-Harris, R., Giribaldi, B., Watts, R., Baker-Jones, M., Murphy-Beiner, A., Murphy, R., Martell, J., Blemings, A., Erritzoe, D., & Nutt, D. J. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2032994 · Cited by 1,391
Self-citationTowards an understanding of psychedelic-induced neuroplasticity
Calder, A. E., & Hasler, G. (2023) · Neuropsychopharmacology · doi:10.1038/s41386-022-01389-z · Cited by 313
“These effects are commonly described in terms of learning experiences [154, 158].”
BackgroundAday, J. S., Davis, A. K., Mitzkovitz, C. M., Bloesch, E. K., & Davoli, C. C. (2021) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.1c00014 · Cited by 224
Timmermann, C., Bauer, P. R., Gosseries, O., Vanhaudenhuyse, A., Vollenweider, F., Laureys, S., Singer, T., Antonova, E., & Lutz, A. (2023) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2022.11.006 · Cited by 150
Peill, J. M., Trinci, K. E., Kettner, H., Mertens, L. J., Roseman, L., Timmermann, C., Rosas, F. E., Lyons, T., & Carhart-Harris, R. L. (2022) · Journal of Psychopharmacology · doi:10.1177/02698811211066709 · Cited by 141
Self-citation
Metadata
- Authors
- Brouwer, A., & Carhart-Harris, R. L.
- Venue
- Journal of Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2020-11-11
- Volume
- 35
- Issue
- 4
- Pages
- 319-352
- ISSN
- 0269-8811 (ISSN-L)
- 1461-7285
- OpenAlex
- W3100714436
- Cited by
- 143
- References
- 168
- FWCI
- 6.97
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.